Verve Therapeutics Inc

XNAS: VERV

Momentum Trap

Download real time

5.77 0.22 (3.96%)

57.67% Fall from 52W High

465.2K XNAS Volume

XNAS 24 Mar, 2025 1:50 PM (EDT)

512.4

Market Cap

Below industry Median

0.0

Beta 1Year

Very Low volatility

Verve Therapeutics Inc - VERV - stock price prediction, stock price target, analyst ratings from 10 analysts

Verve Therapeutics Inc has a share price target of US$ 23, revenue growth forecast of -25.3%, and profit growth estimate of -27.7% for FY25, based on top 10 analyst calls.

Forecaster Screeners